No profile data available.
Illumina, Inc. (ILMN) is a healthcare company in the biological analysis equipment industry, based in San Diego, United States, with about 8,600 full-time employees.
It reported revenue of $4.34 billion for fiscal year 2025, and net income of $850.00 million. United States was its largest region in fiscal year 2025, with 52% of revenue. Its market capitalization was $42.00 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Illumina reported $4.34 billion in revenue for fiscal year 2025.
United States: 52% of revenue by region in fiscal year 2025, followed by Europe (29%).
$42.00 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Danaher Corporation (DHR), Agilent Technologies, Inc. (A), Mettler-Toledo International Inc. (MTD), Revvity, Inc. (RVTY).